BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 12886247)

  • 1. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.
    Schwartz S; Rieder H; Schläger B; Burmeister T; Fischer L; Thiel E
    Leukemia; 2003 Aug; 17(8):1589-95. PubMed ID: 12886247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.
    Behm FG; Smith FO; Raimondi SC; Pui CH; Bernstein ID
    Blood; 1996 Feb; 87(3):1134-9. PubMed ID: 8562939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
    Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
    Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia.
    Hilden JM; Smith FO; Frestedt JL; McGlennen R; Howells WB; Sorensen PH; Arthur DC; Woods WG; Buckley J; Bernstein ID; Kersey JH
    Blood; 1997 May; 89(10):3801-5. PubMed ID: 9160687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L; Bicciato S; te Kronnie G; Basso G
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.
    Mauvieux L; Delabesse E; Bourquelot P; Radford-Weiss I; Bennaceur A; Flandrin G; Valensi F; MacIntyre EA
    Br J Haematol; 1999 Dec; 107(3):674-6. PubMed ID: 10583275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
    Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of fusion gene and immunophenotype in MLL gene rearrangement positive childhood acute lymphoblastic leukemia].
    Gao C; Zhao W; Liu Y; Gong WY; Li WJ; Li ZG; Wu MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1283-8. PubMed ID: 19840468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
    Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
    Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic leukemia with mature B-cell phenotype in infancy.
    Frater JL; Batanian JR; O'Connor DM; Grosso LE
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):672-7. PubMed ID: 15454841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the use of NG2 antigen as a marker to predict MLL rearrangements in multi-center studies.
    Emerenciano M; Renaud G; Sant'Ana M; Barbieri C; Passetti F; Pombo-de-Oliveira MS;
    Leuk Res; 2011 Aug; 35(8):1001-7. PubMed ID: 21444110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
    Smith FO; Rauch C; Williams DE; March CJ; Arthur D; Hilden J; Lampkin BC; Buckley JD; Buckley CV; Woods WG; Dinndorf PA; Sorensen P; Kersey J; Hammond D; Bernstein ID
    Blood; 1996 Feb; 87(3):1123-33. PubMed ID: 8562938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
    Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission.
    Janssen JW; Ludwig WD; Borkhardt A; Spadinger U; Rieder H; Fonatsch C; Hossfeld DK; Harbott J; Schulz AS; Repp R
    Blood; 1994 Dec; 84(11):3835-42. PubMed ID: 7949140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.
    Liu L; McGavran L; Lovell MA; Wei Q; Jamieson BA; Williams SA; Dirks NN; Danielson MS; Dubie LM; Liang X
    Am J Clin Pathol; 2004 Jun; 121(6):810-5. PubMed ID: 15198352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
    Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
    Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.
    Lopez-Millan B; Sanchéz-Martínez D; Roca-Ho H; Gutiérrez-Agüera F; Molina O; Diaz de la Guardia R; Torres-Ruiz R; Fuster JL; Ballerini P; Suessbier U; Nombela-Arrieta C; Bueno C; Menéndez P
    Leukemia; 2019 Jul; 33(7):1557-1569. PubMed ID: 30635633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
    Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
    Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.